miR-214 Attenuates Aortic Valve Calcification by Regulating Osteogenic Differentiation of Valvular Interstitial Cells.
miR-214 Attenuates Aortic Valve Calcification by Regulating Osteogenic Differentiation of Valvular Interstitial Cells.
复制标题
miR-214 通过调节瓣膜间质细胞的成骨分化减轻主动脉瓣钙化
DOI:
10.1016/j.omtn.2020.10.016
复制
发表时间:
2020-12-04
期刊:
影响因子:
--
通讯作者:
Xu Z
中科院分区:
文献类型:
--
作者:
Li N;Bai Y;Zhou G;Ma Y;Tan M;Qiao F;Li X;Shen M;Song X;Zhao X;Liu X;Xu Z
Calcific aortic valve disease (CAVD) is a common heart valve disease in aging populations, and aberrant osteogenic differentiation of valvular interstitial cells (VICs) plays a critical role in the pathogenesis of ectopic ossification of the aortic valve. miR-214 has been validated to be involved in the osteogenesis process. Here, we aim to investigate the role and mechanism of miR-214 in CAVD progression. miR-214 expression was significantly downregulated in CAVD aortic valve leaflets, accompanied by upregulation of osteogenic markers. Overexpression of miR-214 suppressed osteogenic differentiation of VICs, while silencing the expression of miR-214 promoted this function. miR-214 directly targeted ATF4 and Sp7 to modulate osteoblastic differentiation of VICs, which was proved by dual luciferase reporter assay and rescue experiment. miR-214 knockout rats exhibited higher mean transvalvular velocity and gradient. The expression of osteogenic markers in aortic valve leaflets of miR-214 knockout rats was upregulated compared to that of the wild-type group. Taken together, our study showed that miR-214 inhibited aortic valve calcification via regulating osteogenic differentiation of VICs by directly targeting ATF4 and Sp7, indicating that miR-214 may act as a profound candidate of targeting therapy for CAVD. miR-214 imbalance in aortic valve leaflets is responsible for the progress of calcific aortic valve disease (CAVD). Downregulation of miR-214 eliminates its inhibitory effect on translation of Sp7 and ATF4, thereby promoting the development of CAVD. These results suggested that miR-214 might provide an avenue for treating CAVD.
登录
查看更多内容
影响因子:
16.6
作者:
Li D;Liu J;Guo B;Liang C;Dang L;Lu C;He X;Cheung HY;Xu L;Lu C;He B;Liu B;Shaikh AB;Li F;Wang L;Yang Z;Au DW;Peng S;Zhang Z;Zhang BT;Pan X;Qian A;Shang P;Xiao L;Jiang B;Wong CK;Xu J;Bian Z;Liang Z;Guo DA;Zhu H;Tan W;Lu A;Zhang G
通讯作者:
Zhang G
影响因子:
5.4
作者:
Song R;Fullerton DA;Ao L;Zhao KS;Reece TB;Cleveland JC Jr;Meng X
通讯作者:
Meng X
影响因子:
4.6
作者:
Coffey S;Williams MJ;Phillips LV;Galvin IF;Bunton RW;Jones GT
通讯作者:
Jones GT
影响因子:
4.6
作者:
Roberto VP;Gavaia P;Nunes MJ;Rodrigues E;Cancela ML;Tiago DM
通讯作者:
Tiago DM
影响因子:
4.6
作者:
Rathan S;Ankeny CJ;Arjunon S;Ferdous Z;Kumar S;Fernandez Esmerats J;Heath JM;Nerem RM;Yoganathan AP;Jo H
通讯作者:
Jo H